MVA Oncology Network meeting

Welcome to MVA Oncology Network and our 7th meeting – Oncology Animal Models

Oncology is one of the leading areas of research resulting in new therapeutics. Due to the challenges inherent in researching and developing anticancer therapeutics, predictive and robust preclinical models and approaches are critical.

Medicon Valley Alliance, together with one of our members – Envigo – is happy to invite you to the 7th MVA Oncology Network meeting, where we will discuss oncology animal models. What are the current opportunities and challenges of animal models – how do we ensure to get successful animal model translation to clinical practice?

Sign up

The network
MVA Oncology Network is a professional and social network for professors, PI and corporate level executives from the regional oncology eco-system. The network focuses on best practice, experience and current challenges for public-private collaboration and the commercialization of oncology related R&D in the Medicon Valley region.

Joining the network is free of charge and is limited to Medicon Valley Alliance members only. However, non-member organizations and companies are welcome to attend one network event to evaluate if joining the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically make you able you to join the oncology network.

Program
Moderator: Ramin Massoumi, Professor, Lund University

17:00-17:30	Registration, networking and a bite to eat – meet the fellow participants
17:30-17.35	Welcome  Helen Pettersson, Senior Project Manager, Medicon Valley Alliance Markus Axelsson, Sales Director – RMS Benelux & Scandinavia, Envigo
17:35-17:40	Sponsor of the event Jens Viktor Nørgaard, Partner, European Patent Attorney, HØIBERG   HØIBERG
17:40-18.10	“Who are we?” 4 x 5 minute corporate/academic presentations Markus Axelsson, Sales Director – RMS Benelux & Scandinavia, Envigo Ramin Massoumi, Professor, Lund University Tuula Kallunki, Associate Professor, Danish Cancer Society Research Center
18:10-18.40	Mouse models for cancer immunotherapy Maria Askmyr, Senior Scientist, Alligator Bioscience
18:40-19.05	Orthoxenografts derived from adult and children. Present and future for the development of personalized medicine approaches Alberto Villanueva, CSO & Co-founder, Xenopat, Spain
19:05-19.25	Safety testing of anti-cancer products; regulatory requirements and species selection   Andy Makin, Scientific Director, Citoxlab Denmark
19.25-19.30	Concluding remarks Markus Axelsson, Sales Director – RMS Benelux & Scandinavia, Envigo Helen Pettersson, Senior Project Manager, Medicon Valley Alliance
19:30-20:00	Networking and refreshments

Host and sponsor	Sponsor

MVA Oncology Network is a partnership between